Outlook Therapeutics Inc — Balance Sheet (NASDAQ:OTLK) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 19.73 M22.81 M28.53 M32.3 M28.82 M18.58 M Total liabilities 16.91 M18.2 M19.79 M46.74 M101.9 M50.77 M Total equity 2.83 M4.61 M8.74 M-14.44 M-73.08 M-32.19 M Total liabilities & shareholders' equities 19.73 M22.81 M28.53 M32.3 M28.82 M18.58 M Total debt —————— Net debt ——————

Noticias

Outlook Therapeutics analiza reunión con la FDA sobre bevacizumab

Outlook Therapeutics analiza reunión con FDA sobre bevacizumab

Outlook Therapeutics discusses FDA meeting on bevacizumab drug

Oncobiologics, Inc. (OTLK) Reports Q1 Loss, Misses Revenue Estimates

OTLK Stock Crashes 67% in a Week: Here's What You Need to Know

Objetivo de precio de las acciones de Outlook Therapeutics reducido a 0,50 dólares en H.C. Wainwright

H.C. Wainwright reduce precio objetivo de Outlook Therapeutics a $0.50

Outlook Therapeutics stock price target lowered to $0.50 at H.C. Wainwright

Dow Jumps Over 300 Points On First Trading Day Of 2026: Fear & Greed Index Remains In 'Neutral Zone - Micron Technology (NASDAQ:MU), NVIDIA (NASDAQ:NVDA)

The Narrowing Pathway for Biotech Securities Fraud Claims: Lessons from Outlook Therapeutics - TipRanks.com

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.66%

Las bolsas de valores de Estados Unidos se mostraron sin cambios al cierre; el Dow Jones Industrial Average ganó un 0.66%